Allspring Global Investments Holdings, LLC Fulcrum Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	BUY	$4.92 - $9.1 $45,145 - $83,501	9,176 New	9,176 $74,000
Q2 2022 Jul 25, 2022	SELL	$4.2 - $24.0 $22,163 - $126,648	-5,277 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$9.96 - $23.65 $5,926 - $14,071	-595 Reduced 10.13%	5,277 $124,000
Q4 2021 Jan 28, 2022	BUY	$14.0 - $28.44 $82,208 - $166,999	5,872 New	5,872 $103,000

Others Institutions Holding FULC

# of Institutions

150

Shares Held

52.2M

Call Options Held

6.91M

Put Options Held

1.9M

Ra Capital Management, L.P. Boston, MA

10.2M
Shares

$33.2 Million
0.51% of portfolio
Tcg Crossover Management, LLC Palo Alto, CA

5.25M
Shares

$17.1 Million
2.43% of portfolio
Black Rock Inc. New York, NY

4.8M
Shares

$15.6 Million
0.0% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

4.78M
Shares

$15.5 Million
1.01% of portfolio
Vanguard Group Inc Valley Forge, PA

3.27M
Shares

$10.6 Million
0.0% of portfolio

View Full List

About Fulcrum Therapeutics, Inc.

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $169M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

More about FULC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account